As of 2023, the mortality rate for liver malignant neoplasms in Canada stood at approximately 2.34 thousand male deaths. The forecasted data from 2024 to 2028 shows a gradually rising trend, increasing annually from 2.39 to 2.6 thousand male deaths. This represents a steady year-on-year growth rate.
The year-on-year variation is projected to be around 2.5% across each of these years. The compound annual growth rate (CAGR) forecast indicates a consistent upward trend, suggesting a moderate long-term increase in mortality rate.
Future trends to watch include advancements in medical technology and public health initiatives, which may impact these projections. Surveillance of risk factors such as alcohol consumption, obesity, and hepatitis infection rates are critical, as they could alter the trend significantly.
